ChemInform Abstract: 4,10‐Dihydro‐5H‐thieno[3,2‐c][1]benzazepine Derivatives and 9,10‐Dihydro‐4H‐thieno[2,3‐c][1]benzazepine Derivatives as Orally Active Arginine Vasopressin Receptor Antagonists.
Abstract:Active Arginine Vasopressin Receptor Antagonists.-In continuation of developing vasopressin antagonists, the tricyclic pyrrolobenzodiazepine moiety in VPA-985 is replaced by the thienobenzazepine derivatives (IV) and (X). These ring systems are prepared by novel routes, the structure-activity relationship is described. Thienobenzazepines (XII) possess potent V 1a and V 2 receptor binding activity. Compound (XIIc) is a potent, orally active and highly selective V 2 antagonist. -(ARANAPAKAM, VENKATESAN; ALBRIGHT… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.